We are live on ! Find out more
HCA icon

HCA Healthcare

679 hedge funds and large institutions have $28.7B invested in HCA Healthcare in 2019 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 220 increasing their positions, 287 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 64

1% more funds holding

Funds holding: 675679 (+4)

1.05% less ownership

Funds ownership: 71%69.95% (-1.1%)

15% less capital invested

Capital invested by funds: $33.9B → $28.7B (-$5.25B)

18% less funds holding in top 10

Funds holding in top 10: 2218 (-4)

23% less call options, than puts

Call options by funds: $165M | Put options by funds: $214M

23% less repeat investments, than reductions

Existing positions increased: 220 | Existing positions reduced: 287

Holders
679
Holders Change
+4
Holders Change %
+0.59%
% of All Funds
14.89%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.39%
New
71
Increased
220
Reduced
287
Closed
64
Calls
$165M
Puts
$214M
Net Calls
-$49.8M
Net Calls Change
-$9.21M
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
276
AlphaCrest Capital Management
New York
$4.04M +$3.71M +28,697 +595%
RIM
277
Redpoint Investment Management
Australia
$3.91M -$53.5K -414 -1%
NAM
278
Nissay Asset Management
Japan
$3.84M +$157K +1,212 +4%
FTC
279
Farmers Trust Company
Ohio
$3.83M +$914K +7,074 +29%
CAM
280
Cozad Asset Management
Illinois
$3.83M +$154K +1,195 +4%
AC
281
Allstate Corporation
Illinois
$3.82M +$884K +6,837 +27%
Pacer Advisors
282
Pacer Advisors
Pennsylvania
$3.77M +$548K +4,244 +16%
SGA
283
Strategic Global Advisors
California
$3.75M +$3.74M +28,913 +1,309%
OC
284
Oppenheimer & Co
New York
$3.68M -$14.2K -110 -0.4%
FG
285
Formula Growth
Quebec, Canada
$3.61M
II
286
IFM Investors
Australia
$3.61M +$1.28M +9,925 +50%
HIMCH
287
Hartford Investment Management Co (HIMCO)
Connecticut
$3.48M -$47.3K -366 -1%
DKCM
288
Davidson Kempner Capital Management
New York
$3.44M +$3.69M +28,586 New
PAM
289
Panagora Asset Management
Massachusetts
$3.42M -$19.6M -151,555 -84%
Kovitz Investment Group Partners
290
Kovitz Investment Group Partners
Illinois
$3.42M -$297K -2,295 -7%
RIL
291
Rothschild Investment LLC
Illinois
$3.42M
BAMF
292
BI Asset Management Fondsmaeglerselskab
Denmark
$3.38M +$2.71M +20,958 +294%
B
293
BP
United Kingdom
$3.37M
SAM
294
Securian Asset Management
Minnesota
$3.34M -$51.7K -400 -1%
CC
295
Cipher Capital
New York
$3.31M +$1.85M +14,348 +109%
HCMT
296
Highland Capital Management (Tennessee)
Tennessee
$3.26M -$58.5K -453 -2%
PP
297
Paloma Partners
Connecticut
$3.26M +$1.28M +9,922 +58%
OPERF
298
Oregon Public Employees Retirement Fund
Oregon
$3.25M -$179K -1,382 -5%
FM
299
Foster & Motley
Ohio
$3.23M +$318K +2,459 +10%
CIBC Asset Management
300
CIBC Asset Management
Ontario, Canada
$3.23M -$40.4K -313 -1%

HCA Hedge Fund Activity: Q3 2019 in Review

679 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q3 2019, worth a combined $28.7B — down 15% from $33.9B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new HCA positions and 64 closed out — a net gain of 7 holders — while 220 added to existing stakes and 287 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $387M. The largest seller was Fidelity Investments, cutting an estimated $251M.

  • 679 institutional investors held HCA Healthcare (HCA) as of Q3 2019, up from 675 in Q2 2019.
  • Funds reported $28.7B of HCA Healthcare stock for Q3 2019, down 15% quarter-over-quarter.
  • 71 funds opened new HCA Healthcare positions in Q3 2019 and 64 closed out, a net change of +7 holders.
  • The largest HCA Healthcare buyer in Q3 2019 was Wellington Management Group, an estimated $387M added.
  • The largest HCA Healthcare seller in Q3 2019 was Fidelity Investments, an estimated $251M sold.

Based on aggregated 13F filings for Q3 2019.